Combined Hormonal Contraceptives: 3 Methods & Key Benefits
Comprehensive guide to combined hormonal contraceptives: pills, patches, rings, effectiveness, benefits, risks, and usage advice.
Combined hormonal contraceptives (CHCs) are widely used methods that contain both estrogen and progestin, available as oral pills, transdermal patches, and vaginal rings. These methods prevent pregnancy primarily by inhibiting ovulation, thickening cervical mucus, and thinning the endometrium to inhibit implantation.
About Combined Hormonal Contraceptives
CHCs are reversible and suitable for women of all ages, offering high efficacy with approximately seven pregnancies per 100 users in the first year of typical use. Traditional regimens involve 21–24 days of active hormones followed by 4–7 hormone-free days, during which withdrawal bleeding occurs due to falling hormone levels.
Alternative “tailored” regimens, supported by the Faculty of Sexual and Reproductive Healthcare (FSRH), include shortening hormone-free intervals to 4 days, extended use (e.g., tricycling: 9 weeks active followed by 4–7 hormone-free days), flexible extended use until breakthrough bleeding, or continuous use without breaks. These off-label approaches reduce bleeding frequency and may enhance efficacy.
Types of Combined Hormonal Contraceptives
Combined Oral Contraceptive (COC) Pill
The most common CHC, taken daily. Formulations vary (monophasic, biphasic, triphasic, quadriphasic) with different estrogen (usually ethinylestradiol) and progestin doses. Pills with lowest ethinylestradiol and levonorgestrel may have reduced VTE risk.
- Advantages: Highly effective, regulates cycles, reduces cramps, acne, and risks of uterine/ovarian/colon cancer.
- Disadvantages: Daily compliance required; affected by vomiting/nausea; compliance issues lower real-world efficacy.
Combined Transdermal Patch
A weekly patch (e.g., ethinylestradiol/norelgestromin) applied to skin, changed every 7 days for 3 weeks, followed by a patch-free week.
- Advantages: Weekly use; unaffected by nausea/vomiting.
- Disadvantages: Skin irritation/rash; possibly higher breast discomfort, dysmenorrhea, nausea; similar VTE risk, potentially slightly elevated.
Combined Vaginal Ring
A flexible ring (e.g., ethinylestradiol/etonogestrel) inserted vaginally for 21 days, removed for 7 days.
- Advantages: 3-week use; unaffected by diarrhea/vomiting.
- Disadvantages: Vaginal irritation/discharge; headache; intercourse interference; may fall out or break.
How Effective are Combined Hormonal Contraceptives?
With perfect use, CHCs have <1% failure rate; typical use yields 7% pregnancy rate due to compliance issues. Factors reducing efficacy: missed pills, late patch/ring changes, vomiting/diarrhea, drug interactions (e.g., enzyme inducers). Backup contraception needed for 7 days after errors.
| Method | Perfect Use Failure Rate | Typical Use Failure Rate |
|---|---|---|
| COC Pill | 0.3% | 7% |
| Patch | 0.3% | 7% |
| Vaginal Ring | 0.3% | 7% |
Data adapted from CDC USSPR.
Non-Contraceptive Benefits
Beyond contraception, CHCs offer significant health benefits:
- Regular, lighter, shorter periods.
- Reduced menstrual cramps (dysmenorrhea).
- Decreased ovarian, endometrial, colorectal cancer risk.
- Improved acne, reduced hirsutism.
- Treatment for heavy bleeding (menorrhagia), fibroids, endometriosis.
- Continuous use may reduce menstrual migraines (without aura).
Overall, benefits may increase life expectancy despite risks.
Risks and Side Effects
CHCs carry small increased risks of venous thromboembolism (VTE), arterial thrombosis, heart attack, stroke, and certain cancers. VTE risk is highest in first year, higher with patches/rings possibly. Benefits outweigh risks for most; individual assessment via UKMEC criteria essential.
Common side effects: bleeding irregularities (improve with time), nausea, breast tenderness, headaches. Counsel on expectations to improve continuation.
| Risk Factor | Increased Risk with CHC |
|---|---|
| VTE | 2–4 fold (baseline low) |
| Stroke/Heart Attack | Small increase, higher in smokers >35 |
| Breast Cancer | Slight during use, offsets later |
Who Can Use Combined Hormonal Contraceptives? (UKMEC Summary)
Use UK Medical Eligibility Criteria (UKMEC) for assessment. Contraindications include:
- Migraine with aura.
- Current breast cancer.
- Severe liver disease.
- Hypertension (>160/100).
- Smoking >35 years (15+ cigs/day).
- BMI >35 in some cases.
Postpartum: No backup if fully breastfeeding <6 months and amenorrheic; otherwise, abstain or use barriers for 7 days.
Starting Combined Hormonal Contraceptives
Quick Start: Anytime if not pregnant; backup for 7 days.
COC Pill: Days 1–5 of cycle (no backup); otherwise, exclude pregnancy, backup 7 days.
Patch/Ring: Similar; day 1 of cycle ideal.
Postpartum/abortion: Specific timings; >21 days postpartum needs backup if cycle returned.
Missed Pills, Late Patch or Dislodged Ring
COC: Backup 7 days if >1 missed in week 1, late in hormone-free interval, or vomiting within 3 hours. Emergency contraception if unprotected sex.
- Week 1: Take ASAP, continue; backup if >1 miss.
- Week 2/3: Take ASAP, no backup usually.
- Hormone-free: Omit, start new pack.
Patch: Change ASAP; >48h late: backup 7 days.
Ring: Reinsert <3h out ok; >3h: backup 7 days.
Problems with Bleeding Patterns
Breakthrough bleeding common initially, improves with continued use. Advise hormone-free interval of 3–4 days if bothersome (not first 21 days or >once/month). Counseling reduces discontinuation.
Stopping Combined Hormonal Contraceptives
Fertility returns quickly (often immediate). Switch seamlessly to another method. No need to complete cycle unless desired for withdrawal bleed.
Follow-Up
Review 3 months after start, then 6–12 monthly. Annual blood pressure check. Longer supplies (1 year) if stable.
Frequently Asked Questions (FAQs)
Can I use CHCs while breastfeeding?
A: Progestin-only preferred <6 weeks postpartum; CHCs ok after if not fully breastfeeding.
Do CHCs protect against STIs?
A: No; use condoms additionally.
What if I miss more than one pill?
A: Use emergency contraception if within 120 hours of unprotected sex; backup 7 days.
Are tailored regimens safe?
A: Yes, supported by FSRH; may improve compliance.
Which CHC has lowest VTE risk?
A: Lowest ethinylestradiol with levonorgestrel.
References
- Combined Hormonal Contraceptives – CDC — Centers for Disease Control and Prevention. 2024. https://www.cdc.gov/contraception/hcp/usspr/combined-hormonal-contraceptives.html
- Combined hormonal contraception – pill, patch and vaginal ring — Patient.info (FSRH-aligned). 2024. https://patient.info/doctor/fertility/combined-hormonal-contraception-pill-patch-vaginal-ring
- Combined Hormonal Birth Control: Pill, Patch, and Ring — American College of Obstetricians and Gynecologists (ACOG). 2024. https://www.acog.org/womens-health/faqs/combined-hormonal-birth-control-pill-patch-ring
- Combined hormonal contraceptives: prescribing patterns — National Institutes of Health (PMC). 2014-09-29. https://pmc.ncbi.nlm.nih.gov/articles/PMC4212440/
- Combined oral contraceptive pill – follow-up and common problems — Patient.info. 2024. https://patient.info/doctor/drug-therapy/combined-oral-contraceptive-pill-follow-up-and-common-problems
Similar Articles
Read full bio of medha deb
